Discontinued — last reported Q4 '25
Pharmaceuticalsegment — Depreciation
Merck & Co. Pharmaceuticalsegment — Depreciation increased by 100.0% to $2.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $2.00M to $2.00M. Over 4 years (FY 2021 to FY 2025), Pharmaceuticalsegment — Depreciation shows a downward trend with a -4.5% CAGR.
Analysis
How to read this metric
An increase in depreciation may indicate significant recent capital investment in manufacturing or research infrastructure, while a decrease could suggest aging assets or a shift toward asset-light operational models.
Detailed definition
This metric represents the systematic allocation of the cost of tangible assets used specifically within the pharmaceuti...
Peer comparison
Comparable to depreciation and amortization charges reported by other large-cap pharmaceutical companies, though variations exist based on the scale of internal manufacturing versus outsourced production.
mrk_segment_pharmaceutical_segment_depreciationHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.50M | $1.50M | $1.50M | $1.25M | $1.25M | $1.25M | $1.25M | $1.25M | $1.25M | $1.25M | $1.25M | $1.00M | $1.00M | $1.00M | $2.00M | $1.00M | $1.00M | $1.00M | $2.00M |
| QoQ Change | — | +0.0% | +0.0% | -16.7% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -20.0% | +0.0% | +0.0% | +100.0% | -50.0% | +0.0% | +0.0% | +100.0% |
| YoY Change | — | — | — | — | -16.7% | -16.7% | -16.7% | +0.0% | +0.0% | +0.0% | +0.0% | -20.0% | -20.0% | -20.0% | +60.0% | +0.0% | +0.0% | +0.0% | +0.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s pharmaceuticalsegment — depreciation?
- Merck & Co. (MRK) reported pharmaceuticalsegment — depreciation of $2.00M in Q4 2025.
- How has Merck & Co.'s pharmaceuticalsegment — depreciation changed year-over-year?
- Merck & Co.'s pharmaceuticalsegment — depreciation decreased by 0.0% year-over-year, from $2.00M to $2.00M.
- What is the long-term trend for Merck & Co.'s pharmaceuticalsegment — depreciation?
- Over 4 years (2021 to 2025), Merck & Co.'s pharmaceuticalsegment — depreciation has grown at a -4.5% compound annual growth rate (CAGR), from $6.00M to $5.00M.
- What does pharmaceuticalsegment — depreciation mean?
- The non-cash expense representing the portion of the cost of physical assets used in the pharmaceutical segment that is allocated to the current period.